<PubmedArticle>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">25484926</PMID>
<DateCompleted>
<Year>2014</Year>
<Month>12</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Print">1758-9193</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>6</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Alzheimer's research &amp; therapy</Title>
<ISOAbbreviation>Alzheimers Res Ther</ISOAbbreviation>
</Journal>
<ArticleTitle>Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study.</ArticleTitle>
<Pagination>
<MedlinePgn>48</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/alzrt280</ELocationID>
<Abstract>
<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Despite widespread use of second-generation cholinesterase inhibitors for the symptomatic treatment of Alzheimer's disease (AD), little is known about the long term effects of cholinergic treatment on global cognitive function and potential specific effects in different cognitive domains. The objectives of this study were to determine the association between cholinergic treatment and global cognitive function over one and two years in a cohort of patients with mild or moderate AD and identify potential differences in domain-specific cognitive outcomes within this cohort.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A cohort of patients meeting the revised National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria for mild or moderate AD, including patients both on treatment with a cholinesterase inhibitor and untreated controls (treated = 65, untreated = 65), were recruited from the Cognitive Neurology Clinic at Sunnybrook Health Sciences Centre, as part of the Sunnybrook Dementia Study. Patients were followed for one to two years and underwent standardized neuropsychological assessments to evaluate global and domain-specific cognitive function. Associations between cholinesterase inhibitor use and global and domain-specific cognitive outcome measures at one and two years of follow-up were estimated using mixed model linear regression, adjusting for age, education, and baseline mini mental state examination (MMSE).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">At one year, treated patients showed significantly less decline in global cognitive function, and treatment and time effects across tests of executive and visuospatial function. At two years, there was a significant trend towards less decline in global cognition for treated patients. Moreover, treated patients showed significant treatment and time effects across tests of executive functioning, memory, and visuospatial function.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present study offers two important contributions to knowledge of the effectiveness of cholinesterase inhibitor treatment in patients with mild-moderate AD: 1) that second-generation cholinesterase inhibitors demonstrate long-term effectiveness for reducing global cognitive decline over one to two years of follow-up, and 2) that decline in function for cognitive domains, including executive function, memory, and visuospatial skill that are primarily mediated by frontal networks and by the cholinergic system, rather than memory, may be slowed by treatment targeting the cholinergic system.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Behl</LastName>
<ForeName>Pearl</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>L.C.Campbell Cognitive Neurology Research Unit, Toronto, Canada ; University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Edwards</LastName>
<ForeName>Jodi D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>L.C.Campbell Cognitive Neurology Research Unit, Toronto, Canada ; Canadian Partnership for Stroke Recovery, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kiss</LastName>
<ForeName>Alexander</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Brain Sciences Research Program, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lanctot</LastName>
<ForeName>Krista L</ForeName>
<Initials>KL</Initials>
<AffiliationInfo>
<Affiliation>University of Toronto, Toronto, Ontario, Canada ; Brain Sciences Research Program, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada ; Department of Psychiatry, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Streiner</LastName>
<ForeName>David L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry &amp; Behavioral Neurosciences, McMaster University, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Black</LastName>
<ForeName>Sandra E</ForeName>
<Initials>SE</Initials>
<AffiliationInfo>
<Affiliation>L.C.Campbell Cognitive Neurology Research Unit, Toronto, Canada ; University of Toronto, Toronto, Ontario, Canada ; Brain Sciences Research Program, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada ; Department of Medicine (Neurology), Toronto, Ontario, Canada ; Department of Psychology, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stuss</LastName>
<ForeName>Donald T</ForeName>
<Initials>DT</Initials>
<AffiliationInfo>
<Affiliation>University of Toronto, Toronto, Ontario, Canada ; Department of Medicine (Neurology), Toronto, Ontario, Canada ; Department of Psychology, Toronto, Ontario, Canada ; Ontario Brain Institute, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>08</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Alzheimers Res Ther</MedlineTA>
<NlmUniqueID>101511643</NlmUniqueID>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2013</Year>
<Month>05</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2014</Year>
<Month>07</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>12</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>12</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>12</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25484926</ArticleId>
<ArticleId IdType="doi">10.1186/alzrt280</ArticleId>
<ArticleId IdType="pii">alzrt280</ArticleId>
<ArticleId IdType="pmc">PMC4255390</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Arch Neurol. 1997 Jun;54(6):719-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9193207</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropsychologia. 1999 Oct;37(11):1251-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10530725</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Geriatr Psychiatry Neurol. 2006 Mar;19(1):13-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16449754</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2004 Jun 26;363(9427):2105-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15220031</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Alzheimer Dis Assoc Disord. 2000 Apr-Jun;14(2):81-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10850746</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Neurol Scand. 2003 Aug;108(2):82-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12859283</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drugs Aging. 2003;20(10):777-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12875613</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Psychiatry Rep. 2004 Feb;6(1):20-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14738700</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroreport. 1995 Jun 19;6(9):1297-300</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7669991</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CMAJ. 2003 Sep 16;169(6):557-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12975222</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropsychology. 1998 Oct;12(4):565-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9805326</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropsychologia. 1996 Jun;34(6):537-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8736567</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 2008 Mar 4;148(5):379-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18316756</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2004 Jul 1;351(1):56-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15229308</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Health Technol Assess. 2012;16(21):1-470</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22541366</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Geriatr Psychiatry. 2005 May;20(5):485-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15852461</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 2001 Aug 14;57(3):481-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11502917</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Alzheimer Res. 2006 Apr;3(2):147-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16611015</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Aging. 1997 Mar;12(1):183-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9100279</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Ther. 2012 Apr;134(1):8-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22198801</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Neurol. 2004 Apr;11(4):253-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15061827</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol Neurosurg Psychiatry. 2005 Dec;76 Suppl 5:v2-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16291918</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2009 Dec 16;302(23):2557-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20009055</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cereb Cortex. 2001 Nov;11(11):1083-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11590117</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Int Neuropsychol Soc. 2001 Jul;7(5):631-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11459114</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Alzheimers Dement. 2011 May;7(3):263-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21514250</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16437532</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cortex. 1999 Feb;35(1):57-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10213534</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Behav Brain Res. 1997 Feb;83(1-2):15-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9062655</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropsychol Rev. 2005 Mar;15(1):1-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15929495</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Psychiatr Res. 1975 Nov;12(3):189-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1202204</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Int Neuropsychol Soc. 1998 May;4(3):265-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9623001</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol Neurosurg Psychiatry. 2004 May;75(5):677-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15090558</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Speech Lang. 2002 May;23(2):139-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11951174</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Exp Neuropsychol. 1991 Sep;13(5):752-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1955530</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Exp Neuropsychol. 1995 May;17(3):459-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7650107</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Haemostasis. 1998 May-Aug;28(3-4):117-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10420059</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Geriatr Med. 2001 May;17(2):337-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11375139</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Psychiatry. 1988 Feb 1;23(3):271-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3337862</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Learn Mem. 2004 Jan-Feb;11(1):43-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14747516</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Can J Neurol Sci. 2005 May;32(2):140-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16018149</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Cogn. 2003 Nov;53(2):197-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14607147</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Aging. 1996 Sep;11(3):387-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8893308</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Neurol. 2004 Apr;61(4):556-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15096405</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Open Med. 2009 Mar 24;3(2):e31-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19946392</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurologia. 2001 Oct;16(8):342-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11738011</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Psychogeriatr. 2008 Dec;20(6):1141-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18606043</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Neurol. 1999 May;56(5):587-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10328254</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Psychopharmacol. 2005 Aug;20(6):409-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15991260</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Cogn. 2001 Jun-Jul;46(1-2):264-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11527345</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 2001 Aug 14;57(3):489-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11502918</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain. 2003 Jun;126(Pt 6):1493-503</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12764068</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain. 1992 Jun;115 ( Pt 3):711-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1628198</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropsychologia. 1998 Sep;36(9):901-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9740363</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Nucl Med. 2001 Oct;42(10 ):1441-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11585854</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Med. 1987 May;17(2):329-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3299440</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Geriatr Psychiatry. 2006 Jan;21(1):17-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16323253</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Exp Neuropsychol. 1986 Jun;8(3):201-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3722347</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychopharmacology (Berl). 1993;110(4):395-401</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7870908</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Psychiatry. 1994 Mar;151(3):390-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8109647</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):310-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11861686</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):81-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7823074</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dement Geriatr Cogn Disord. 2005;19(1):51-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15383747</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 2000 Jun 27;54(12):2261-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10881250</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>No To Shinkei. 2004 Jan;56(1):42-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15024828</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol Neurosurg Psychiatry. 1994 Nov;57(11):1389-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7964817</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 1990 Aug;40(8):1225-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2381530</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Interv Aging. 2008;3(2):211-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18686744</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Geriatr Psychiatry. 2004 Jul-Aug;12(4):358-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15249273</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>